Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Rodovre, Denmark Clinical Trials

A listing of Rodovre, Denmark clinical trials actively recruiting patients volunteers.

RESULTS

Found (15) clinical trials

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.

Phase

1.54 miles

Learn More »

The Hemodynamics Effect of Levcromakalim After Glibenclamide Administration Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study With Healthy Volunteers

12 healthy participants will randomly be allocated to receive levcromakalim or placebo on to different days efter oral glibenclamide administration. The aim of the study is to investigate the effect of levcromakalim/placebo infusion on cranial arteries after glibenclamide administration. Repeated magnetic resonance angiography (MRA) measurements covering the middle meningeal artery ...

Phase N/A

1.54 miles

Learn More »

The Effects of Maxipost (BMS 204352) on Cerebral Hemodynamic and Headache in Healthy Volunteers and Migraine Patients

It is not previously investigated whether, there is a correlation between potassium channels and migraine, so it is unclear whether, this signaling pathway through potassium channels has an impact on migraine pathophysiology. Maxipost (BMS 204352) is a vasoactive molecule that causes vasodilation via the big calcium dependent potassium (BKCa) channel ...

Phase N/A

1.54 miles

Learn More »

Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients

To investigate the role of KATP channels in migraine with aura patients.

Phase N/A

1.54 miles

Learn More »

CDI Synbiotic Study

Probiotics have been tested for their efficacy in preventing infection with C. difficile after antibiotic exposure. Some of the most effective probiotics tested Lactobacillus rhamnosus (LGG), Lactobacillus acidophilus (LA-5), Lactobacillus paracasei (L. casei 431) and Bifidobacterium lactis (BB-12). However, most studies have focused on prevention of the first incidence of ...

Phase N/A

3.37 miles

Learn More »

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1 3 8 and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

This is a double-blind, multi-centre, randomised, 5-arm, vehicle-controlled, parallel-group trial. The trial is designed to establish a dose-response signal and to investigate the efficacy and safety of delgocitinib cream in the treatment of adult subjects with mild to severe chronic hand eczema.

Phase

3.49 miles

Learn More »

Patient-reported Outcomes in Bladder Cancer

Bladder cancer is in Europe the 4th most incident cancer among men and the 7th most frequent cause of cancer death. Many patients will receive chemo- or immunotherapy in either the neoadjuvant setting or for recurrent or metastatic disease. The registration and handling of side effect is crucial in bladder ...

Phase N/A

3.49 miles

Learn More »

Querying Stroke Unit Nursing Interventions in the Emergency Department

An intervention study comprised of 1) a primary registry database component and 2) a secondary questionnaire based quantitative evaluation . The intervention study includes a 3-month baseline observational period followed by a 7-month baseline data collection period, a 2-month intervention implementation phase, and a 3-month intervention observational period followed by ...

Phase N/A

3.49 miles

Learn More »

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

This is an open-label, multicentre, multi-drug, biomarker-directed Phase 2 platform study in patients with advanced non-small cell lung cancer (NSCLC) harbouring an epidermal growth factor receptor (EGFR)-sensitizing mutation whose disease has progressed on first-line monotherapy with osimertinib.Treatment options for these patients are limited. Novel treatments for these patients are urgently ...

Phase

3.49 miles

Learn More »

A Study of Deflazacort (Emflaza ) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)

This study is designed to evaluate the safety and efficacy of deflazacort in participants with LGMD2I. The study will include a 26-week double-blind, randomized, placebo-controlled period followed by a 26-week open-label extension period during which all participants will receive deflazacort.

Phase

3.85 miles

Learn More »